Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjogren's syndrome.

ABSTRACT:

SUBMITTER: Zhao SS 

PROVIDER: S-EPMC10473269 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature